Business Overview
2019
Founded
155
Team
2.3%
Growth (Monthly CAGR)
$295M
Funding
3
# Rounds
16
# Investors
1.9 years
Time Since Last Round
Employee Count
2.3%
1-Month CAGR
6.6%
3-Month CAGR
13.4%
6-Month CAGR
28.5%
12-Month CAGR
Employee counts updated on a monthly basis.
Lists
News
ㅤTitle | Date | |
---|---|---|
![]() | ㅤTLV Partners closes $250m VC fund | Globes | July 17, 2023 |
![]() ![]() ![]() | ㅤTLV Partners closes $250m VC fund | Globes | July 17, 2023 |
![]() ![]() ![]() | ㅤTLV Partners Launches $250M Early-Stage Israeli Startups Fund V | FinSMEs | July 17, 2023 |
Stock Chart
Founders (5)
ㅤName | Title | Contact | |
---|---|---|---|
![]() ![]() ![]() | ㅤNoam Solomon | CEO | 1 |
![]() ![]() ![]() | ㅤLuis Voloch | CTO | 1 |
![]() ![]() ![]() | ㅤDanny Wells | Scientific Founder | 1 |
![]() ![]() ![]() | ㅤAnsuman Satpathy | Scientific Founder | |
![]() ![]() ![]() | ㅤDan Littman | Scientific Founder | 1 |
Board and Advisors (11)
ㅤName | Title | Contact | |
---|---|---|---|
![]() ![]() ![]() | ㅤSteven Averbuch | Advisor | |
![]() ![]() ![]() | ㅤRegina Barzilay | Advisor | |
![]() ![]() ![]() | ㅤRahul Satija | Advisor | |
![]() ![]() ![]() | ㅤMatthew Hellmann | Advisor | |
![]() ![]() ![]() | ㅤMichael Aberman | Advisor | |
![]() ![]() ![]() | ㅤMichael Kalos | Advisor | 1 |
![]() ![]() ![]() | ㅤKimary Kulig | Advisor | |
![]() ![]() ![]() | ㅤLarry Marton | Advisor | |
![]() ![]() ![]() | ㅤLaurence Nore | Advisor | 1 |
![]() ![]() ![]() | ㅤJimmie Ye | Advisor | |
![]() ![]() ![]() | ㅤDan Littman | Advisor |
Funding Rounds (3)
M&A Events (2)
Title | Date Announced | Amount ($) | |
---|---|---|---|
![]() ![]() ![]() | ㅤImmunai Startup Acquisition | July 2021 | 0 |
![]() ![]() ![]() | ㅤImmunai Startup Acquisition | March 2021 | 0 |
Investors (17)
ㅤInvestor Name | Investor Type | AUM ($) | |
---|---|---|---|
![]() ![]() ![]() | ㅤ8VC | Venture Capital | $1.5B |
![]() ![]() ![]() | ㅤAlexandria Venture Investments | Corporate Venture Capital | $737.1M |
![]() ![]() ![]() | ㅤCatalio Capital Management | Venture Capital | |
![]() ![]() ![]() | ㅤDexcel Pharma | Company | |
![]() ![]() ![]() | ㅤDuquesne Family | Family Office | |
![]() ![]() ![]() | ㅤGefen Capital | Venture Capital | |
![]() ![]() ![]() | ㅤICON | ||
![]() ![]() ![]() | ㅤICON | Accelerator | $11.6M |
![]() ![]() ![]() | ㅤKoch Disruptive Technologies | Corporate Venture Capital | |
![]() ![]() ![]() | ㅤMeron Capital | Venture Capital | $50M |
![]() ![]() ![]() | ㅤPerot Jain | Venture Capital | |
![]() ![]() ![]() | ㅤPiedmont | ||
![]() ![]() ![]() | ㅤR-Squared Ventures | Venture Capital | |
![]() ![]() ![]() | ㅤSchusterman Family Investments | Family Office | |
![]() ![]() ![]() | ㅤTalos VC | Family Office | |
![]() ![]() ![]() | ㅤTLV Partners | Venture Capital | $1.05B |
![]() ![]() ![]() | ㅤViola Ventures | Venture Capital | $1.27B |
Patents (2)
Patent Title | Status |
---|---|
A system for predicting treatment outcomes based upon genetic imputation | Application |
System for predicting treatment outcomes based upon genetic imputation | Application |
Research Publications (8)
Certifications (0)
AI Technology Stack
10
AI Team
Immunai’s mission is to map the immune system with neural networks and transfer learning techniques informed by deep immunology knowledge. We developed the tools and knowhow to help every immuno-oncology and cell therapy researcher excel at their job. Immunai combines comprehensive, multi-omic single cell genomics with cutting edge machine learning algorithms to enable high resolution profiling of the immune system, at industrial scale, with rapid turnaround.
Jobs (0)